The gut houses approximately 70% of the immune system
Not all applied product reaches target cells, so formulations include buffer above the minimum effective dose
Full article here: #SyntheticPeptides, #TherapeuticPeptides, #Pharmaceuticals, TIDES: Oligonucleotides and Peptide Therapeutics USA 2026, #CDMO, #SPPS, #PeptideManufacturing, #GLP1, Corden Pharma - A Full-Service CDMO, Bachem, WuXi AppTec TIDES, Cambrex, Asymchem Group, PolyPeptide Group Laboratories, SK pharmteco, Axplora, Neuland Laboratories Limited, Almac Group To view or add a comment, sign in Global demand for peptide therapeutics continues to rise, increasing the importance of CDMOs capable of efficient, reliable scaleup
If you appreciate ingredients designed for specific applications rather than general-purpose products, AHK-Cu fits that philosophy
together, they form a potent synergy